- Home
- SABA vs ACB Comparison
SABA vs ACB Comparison
Compare SABA & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SABA | ACB |
|---|---|---|
| Founded | 1988 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Pharmaceuticals and Biotechnology |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 225.6M | 188.3M |
| IPO Year | 1994 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SABA | ACB |
|---|---|---|
| Price | $8.52 | $3.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 57.7K | ★ 1.4M |
| Earning Date | 01-01-0001 | 06-17-2026 |
| Dividend Yield | ★ 12.91% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.31 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.96 | $3.07 |
| 52 Week High | $9.46 | $6.67 |
Technical Indicators
Market Signals| Indicator | SABA | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 57.14 | 47.33 |
| Support Level | $8.24 | $3.22 |
| Resistance Level | $8.90 | $3.91 |
| Average True Range (ATR) | 0.14 | 0.21 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 53.76 | 17.22 |
Price Performance
Historical ComparisonAbout SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.
About ACB Aurora Cannabis Inc.
Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.